IBIO-301

N/A

Report date: 2023/07/17 18:06:29

Base Information

Drug NameIBIO-301

Drug Alias NameIBIO-301IBIO301

ClassificationBiologics

Mechanisms of ActionLeukocyte immunoglobulin-like receptor subfamily B member 2 inhibitorsLeukocyte immunoglobulin-like receptor B1 inhibitorsT lymphocytes stimulants +[4]

TargetsLeukocyte immunoglobulin-like receptor B1Leukocyte immunoglobulin-like receptor subfamily B member 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmune Biosolutions Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmune Biosolutions Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A